Jon Edwards, Ph.D. | Non-executive Director
Jon Edwards is a Principal on the investment team at Medicxi, with a primary focus on early-stage opportunities. Prior to Medicxi, Jon worked at Index as an associate and was a life science strategy consultant at ClearView Healthcare Partners.
In addition to being a board member for Xenikos, Jon also serves on the boards of Palladio Biosciences, Z-Factor, UltraHuman Ltd, Sydnexis and Impact Biomedicines (acquired by Celgene) and acts as an observer on the boards of Capella Bioscience and Apcintex.
Jon holds a Ph.D. in biochemistry and biophysics from the University of North Carolina at Chapel Hill and conducted postdoctoral research at MIT.